Ozempic for diabetes: what the TikTok pitch gets right and wrong

What did @endocrinoconeli actually say?

This is a genuinely difficult video to fact-check, and here is why: the transcript is garbled beyond recognition. The caption, written in Spanish, promotes Ozempic as a treatment for diabetes and recommends endocrinologist supervision. The spoken content, however, is incoherent, with phrases like "the first skill is the third skill" repeated without meaning. The video's factual value lives entirely in the caption, not the audio.

The caption states that Ozempic is indicated for diabetes and that its use should always be supervised by an endocrinologist. That is the substance we can evaluate. The creator appears to be a Spanish-speaking endocrinologist using the platform to drive consultations, which means the medical framing matters even if the audio does not hold up.

Does the science back this up?

On the core caption claim, yes. Semaglutide (the active ingredient in Ozempic) is FDA-approved for type 2 diabetes management and has strong evidence behind it. The SUSTAIN trial program, published across multiple papers between 2016 and 2018 in journals including the New England Journal of Medicine and The Lancet Diabetes and Endocrinology, showed consistent HbA1c reductions of 1.0 to 1.8 percentage points versus placebo and active comparators.

The SUSTAIN-6 cardiovascular outcomes trial (Marso et al., 2016, NEJM) further established that semaglutide reduced major adverse cardiovascular events in people with type 2 diabetes at high cardiovascular risk. These are not marginal findings. This drug has a robust evidence base for its labeled indication.

The recommendation for specialist oversight is also supported by clinical guidelines. The American Diabetes Association's Standards of Care in Diabetes (updated annually) and the European Association for the Study of Diabetes both recommend individualized treatment plans managed by qualified clinicians, particularly when injectable therapies are involved.

What did they get wrong (or right)?

The creator got the fundamentals right in the caption. Ozempic is indicated for diabetes. Specialist supervision is appropriate. Neither of those statements is controversial or overstated.

What the video fails to do, and this is a real gap, is provide any nuance about who is and is not a candidate. Ozempic carries a boxed warning for a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It is not appropriate for type 1 diabetes. Pancreatitis has been reported, though causality remains debated (Butler et al., 2013, Diabetes). A responsible clinical video should at minimum flag contraindications rather than presenting the drug as a broadly safe option pending consultation.

The audio transcript is a separate problem. It is either a transcription failure or a meaningless filler track. Either way, it means viewers relying on spoken content received nothing medically useful. That is a content quality issue, not a misinformation issue, but it matters.

What should you actually know?

Semaglutide works by mimicking GLP-1, a hormone that stimulates insulin secretion in response to meals, suppresses glucagon, and slows gastric emptying. It does not cure diabetes. It manages blood glucose and, in some patients, reduces cardiovascular risk. These are meaningfully different things.

Ozempic (0.5 mg, 1 mg, 2 mg weekly injection) is approved for type 2 diabetes. Wegovy (2.4 mg weekly) is the higher-dose formulation approved for chronic weight management. They contain the same molecule at different doses. They are not interchangeable prescriptions, and a clinician needs to determine which, if either, is appropriate for a given patient.

If you are considering semaglutide for diabetes or weight management, the question to ask your provider is not just whether it is safe in general, but whether it is safe for you specifically, given your personal history, current medications, and metabolic goals. That is the conversation the caption is pointing toward, and it is the right one to have.